Elkfork Partners’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-277
| Closed | -$139K | – | 1054 |
|
|
2019
Q2 | $139K | Sell |
277
-87
| -24% | -$43.7K | ﹤0.01% | 892 |
|
|
2019
Q1 | $362K | Sell |
364
-366
| -50% | -$364K | 0.01% | 652 |
|
|
2018
Q4 | $634K | Sell |
730
-348
| -32% | -$302K | 0.02% | 457 |
|
|
2018
Q3 | $1.12M | Buy |
1,078
+73
| +7% | +$75.5K | 0.03% | 357 |
|
|
2018
Q2 | $923K | Buy |
1,005
+26
| +3% | +$23.9K | 0.02% | 362 |
|
|
2018
Q1 | $955K | Buy |
979
+827
| +544% | +$807K | 0.03% | 339 |
|
|
2017
Q4 | $69K | Sell |
152
-102
| -40% | -$46.3K | ﹤0.01% | 969 |
|
|
2017
Q3 | $105K | Sell |
254
-33
| -11% | -$13.6K | ﹤0.01% | 885 |
|
|
2017
Q2 | $100K | Sell |
287
-94
| -25% | -$32.8K | ﹤0.01% | 864 |
|
|
2017
Q1 | $196K | Hold |
381
| – | – | 0.01% | 593 |
|
|
2016
Q4 | $135K | Buy |
+381
| New | +$135K | ﹤0.01% | 664 |
|